TABLE 2.
Laboratory findings in the different cohorts
| Laboratory parameter | Cancer cohort (n = 39) | Noncancer cohort (n = 39) | P‐value | Solid tumors (n = 29) | Hemato‐logical tumors (n = 10) | P‐value |
|---|---|---|---|---|---|---|
| Leukocytes (109/L) | 5.85 | 6.33 | .4263 | 6.28 | 5.63 | .5987 |
| Platelets (109/L) | 175 | 172 | .8990 | 179 | 142 | .2476 |
| Hemoglobin (g/dL) | 10.9 | 12.4 | .2811 | 11.6 | 9.9 | .1428 |
| Neutrophils (109/L) | 4.67 | 4.81 | .7454 | 5.04 | 3.71 | .6168 |
| Lymphocytes (109/L) | 0.57 | 0.85 | .0519 | 0.78 | 0.39 | .0588 |
| D‐Dimers (mg/L) | 2.83 | 1.02 | .1112 | 3.94 | 1.46 | .1076 |
| max. D‐Dimers (mg/L) | 4.03 | 6.03 | .8840 | 3.68 | 4.41 | .6331 |
| LDH (IU/L) | 328 | 344 | .5132 | 318 | 339 | .4120 |
| max. LDH (IU/L) | 396 | 465 | .2744 | 336 | 532 | .1006 |
| CRP (mg/L) | 68 | 64 | .9352 | 51 | 96 | .2005 |
| max. CRP (mg/L) | 127 | 168 | .1017 | 87 | 181 | .1078 |
| PCT (ng/mL) | 0.13 | 0.2 | .0062 | 0.12 | 0.14 | .3197 |
| max. PCT (ng/mL) | 0.22 | 0.77 | .0110 | 0.19 | 0.43 | .1076 |
| IL‐6 (pg/mL) | 47.8 | 82.2 | .0634 | 47.8 | 50.2 | .5063 |
| max. IL‐6 (pg/mL) | 64.5 | 118 | .2481 | 59.5 | 274.5 | .0298 |
| GFR (mL/min) | 70 | 48 | .0260 | 70 | 68 | .5611 |
Abbreviations: CRP, C‐reactive protein; GFR, glomerular filtration rate; IL‐6, interleukin 6; LDH, lactate dehydrogenase; PCT, procalcitonin.